Pirogov Russian National Research Medical University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Moscow Russian Federation (1906)

Organization Overview

First Clinical Trial
2010
NCT01113346
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Center of Personalized Medicine, Pirogova | Department of Neurology and Neurosurgery, N. M. Pirogov Russian National Research Medical University, Moscow | Federal State Budgetary Institution - N.I. Pirogov National Medical and Surgical Center, Ministry of Health of the Russian Federation | National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation | N.I. Pirogov National Medical and Surgical Center | N. M. Pirogov Russian National Research Medical University, Moscow | Pirogov National Medical and Surgical Center | Pirogov National Medical Surgical Center | Pirogov RNRMU | Pirogov Russian National Research Medical University | Provincial Specialist Hospital M. Pirogowa in Łódź | State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | St. Vladimir Children's Moscow Clinical Hospital | St. Vladimir Moscow Children's Clinical Hospital | Vinnitsa Regional Clinical Hospital Named after N.I.Pirogov | Vinnytsia Regional Pirogov Clinical Hospital | Wojewódzki Specjalistyczny Szpital im. M. Pirogowa w Łodzi

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenovirus Infections, Human (Phase 3)

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Communicable Diseases (Phase 2)

Embolism (Phase 3)

Enteritis (Phase 3)

Enterovirus Infections (Phase 3)

Gastroenteritis (Phase 3)

Hodgkin Disease (Phase 3)

Infections (Phase 2)

Ischemia (Phase 3)

Kidney Failure, Chronic (Phase 2)

Lymphoma (Phase 3)

Postphlebitic Syndrome (Phase 4)

Postthrombotic Syndrome (Phase 4)

Pseudomonas Infections (Phase 2)

Pulmonary Embolism (Phase 3)

Renal Insufficiency (Phase 2)

Short Bowel Syndrome (Phase 2)

Stroke (Phase 3)

Syndrome (Phase 2)

Thrombosis (Phase 4)

Urinary Tract Infections (Phase 2)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 34